Oleanolic Acid Market Size To Reach $127.10 Million By 2033

Oleanolic Acid Market Growth & Trends

The global oleanolic acid market size is projected to reach USD 127.10 million by 2033, expanding at a CAGR of 7.3% from 2025 to 2033, according to Grand View Research, Inc. The market is gaining momentum due to the accelerating demand for bio-based active ingredients in therapeutic and cosmetic formulations that promote long-term health benefits. Increasing consumer awareness about the adverse effects of chemical-based pharmaceuticals is encouraging the adoption of natural triterpenoids like oleanolic acid in the formulation of liver-protective and metabolic health products. Moreover, the growing emphasis on personalized nutrition and preventive healthcare solutions is compelling nutraceutical and functional food manufacturers to incorporate oleanolic acid as a key natural compound to enhance product efficacy and market appeal.

Expanding research into multi-functional natural molecules is creating promising opportunities for the broader utilization of oleanolic acid across emerging product categories. Its demonstrated potential in anti-cancer, antimicrobial, and anti-obesity applications is encouraging pharmaceutical innovators to explore new drug delivery systems and combination therapies. Additionally, the surge in demand for clean-label skincare and anti-aging formulations presents a profitable niche for cosmetic brands to leverage oleanolic acid as a bioactive ingredient that aligns with the rising global preference for plant-derived and eco-conscious products.

The Natural segment dominated the source segment with a revenue share of 54.34% in 2024. The market is driven by increasing industrial reliance on botanically sourced actives that align with the clean-label and sustainability commitments of major pharmaceutical and cosmetic brands. The natural variant’s traceability, eco-friendly extraction methods, and regulatory acceptance under global herbal ingredient standards have reinforced its credibility in international markets. Supported by consistent investment in improving raw material cultivation and refining extraction yields, naturally derived oleanolic acid continues to command the largest market share, reflecting its established reputation for safety, authenticity, and therapeutic reliability.

The pharmaceutical segment dominated the application segment with a revenue share of 45.67% in 2024, largely driven by the compound’s expanding use in evidence-based formulations targeting inflammatory, hepatic, and metabolic disorders. The segment’s rapid expansion is supported by intensified R&D and the development of advanced drug delivery systems that enhance the compound’s bioavailability and therapeutic stability. Continuous regulatory support for botanical-based APIs and integration into modern treatment frameworks have further positioned oleanolic acid as a vital ingredient in the evolving landscape of natural drug innovation.

The liquid segment dominated the product segment with a revenue share of 40.10% in 2024, propelled by its superior dispersion ability, formulation flexibility, and high absorption efficiency in both oral and topical applications. Liquid formulations allow pharmaceutical and cosmetic manufacturers to deliver precise concentrations with greater stability and faster bioactive performance. Ongoing process advancements in solvent extraction and microencapsulation technologies have further improved liquid product consistency, reinforcing its preference across end-use industries seeking enhanced efficacy and formulation versatility.

The Asia Pacific dominated the market with the largest revenue share of 37.54% in 2024. The market, primarily supported by its robust herbal medicine heritage and the rapid industrialization of natural ingredient processing technologies. Countries such as China, India, Japan, and South Korea are increasingly investing in advanced bioactive extraction and pharmaceutical standardization facilities, ensuring consistency and scalability in production. Regional regulatory frameworks that promote the integration of botanical actives into modern therapeutics are further strengthening industrial confidence and cross-border trade. Additionally, the availability of abundant plant raw materials and a strong academic–industry research ecosystem has made Asia-Pacific a central hub for innovation and cost-efficient production in the oleanolic acid industry.

 Request a free sample copy or view report summary: Oleanolic Acid Market Report

Oleanolic Acid Market Report Highlights

• North America is expected to depict a CAGR of 6.8%, primarily supported by its strong consumer shift toward natural and preventive healthcare solutions. The rising preference for plant-based nutraceuticals and functional supplements has encouraged pharmaceutical and wellness brands across the U.S. and Canada to expand portfolios with natural bioactives such as oleanolic acid. High consumer purchasing power and established retail distribution networks amplify product accessibility and market visibility, resulting in sustained regional demand and steady revenue growth across both pharmaceutical and personal care applications.

• U.S. held the largest revenue share in North America in 2024 due to its advanced biomedical research ecosystem and regulatory support that accelerates product innovation. The U.S. Food and Drug Administration (FDA) under the Dietary Supplement Health and Education Act (DSHEA) provides a structured framework for botanical ingredients, allowing oleanolic acid formulations to enter the market with validated safety and quality claims. This regulatory clarity, combined with increasing cases of metabolic and liver-related disorders, is driving pharmaceutical and nutraceutical companies to invest in oleanolic acid-based therapeutics, reinforcing the country’s leadership in innovation and commercialization.

• Germany plays a leading role in the Europe market, supported by its advanced pharmaceutical manufacturing infrastructure and strong focus on natural compound research. The country’s deep integration of chemical engineering with phytochemical innovation allows precise extraction, purification, and stabilization of oleanolic acid for therapeutic and cosmetic applications.

• In June 2024, researchers from the Biomedical Research Institute of Murcia (IMIB) and the Catholic University of Murcia (UCAM), Spain, developed a new cyclodextrin-based formulation to improve the stability and absorption of oleanolic acid in creams and topical products. This innovation aims to make the ingredient more effective for pharmaceutical and skincare applications.

Oleanolic Acid Market Segmentation

Grand View Research has segmented the global oleanolic acid market on the basis of source, end-use, product and region:

Oleanolic Acid Source Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2033)

• Natural

• Synthetic

• Semi-synthetic

Oleanolic Acid End-use Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2033)

• Pharmaceuticals

• Cosmetics & Personal Care

• Food & Beverage

• Other Applications

Oleanolic Acid Product Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2033)

• Powder

• Liquid

• Capsules

• Other Products

Oleanolic Acid Region Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • Saudi Arabia

  • South Africa

List of Key Players in the Oleanolic Acid Market

• SimSon Pharma Limited

• Chemicea Limited

• Otto Chemie Pvt. Ltd.

• Fengchen Group Co.,Ltd

• Xi'an Fengzu Biological Technology Co.,Ltd

• Nutragreenlife Biotechnology Co.,Ltd

• Symrise AG

• Martin Bauer GmbH & Co. KG

• Sensient Technologies Corporation

• Euromed S.C.A.